A
Aquestive Therapeutics D
D
AQST
2.60000
USD
-0.06
(-2.26%)
Post Trading
حجم التداول
16,399
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
257,065,559
الأخبار المقالات
العنوان: Aquestive Therapeutics
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.